Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11316746
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.

  2000cited by this paper
• Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.

  2000cited by this paper
• Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.

  2000cited by this paper
• Glucose-stimulated Preproinsulin Gene Expression and Nucleartrans-Location of Pancreatic Duodenum Homeobox-1 Require Activation of Phosphatidylinositol 3-Kinase but Not p38 MAPK/SAPK2*

  2000cited by this paper
• The glucagon-like peptides.

  1999cited by this paper
• Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A.

  1999cited by this paper
• Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.

  1999cited by this paper
• Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells

  1999cited by this paper
• PKA‐mediated phosphorylation of the human KATP channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation

  1999cited by this paper
• Glucose Stimulates Translocation of the Homeodomain Transcription Factor PDX1 from the Cytoplasm to the Nucleus in Pancreatic β-Cells*

  1999cited by this paper
• Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes.

  1999cited by this paper
• Functional Regulation of L-type Calcium Channels via Protein Kinase A-mediated Phosphorylation of the β2 Subunit*

  1999cited by this paper
• Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells.

  1999cited by this paper
• Transcribing pancreas.

  1998cited by this paper
• A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus.

  1998cited by this paper
• Glucose-dependent Translocation of Insulin Promoter Factor-1 (IPF-1) between the Nuclear Periphery and the Nucleoplasm of Single MIN6 β-Cells*

  1998cited by this paper
• Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1

  1998cited by this paper
• The p38/Reactivating Kinase Mitogen-activated Protein Kinase Cascade Mediates the Activation of the Transcription Factor Insulin Upstream Factor 1 and Insulin Gene Transcription by High Glucose in Pancreatic β-Cells*

  1997cited by this paper
• Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence

  1997cited by this paper
• SNAP-25 is phosphorylated by glucose and GLP-1 in RIN 1046-38 cells.

  1997cited by this paper
• Pseudosubstrate inhibition of cyclic AMP-dependent protein kinase in intact pancreatic islets: effects on cyclic AMP-dependent and glucose-dependent insulin secretion.

  1997cited by this paper
• Overexpression of glucagon-like peptide-1 receptor in an insulin-secreting cell line enhances glucose responsiveness.

  1997cited by this paper
• Anchoring of protein kinase A facilitates hormone-mediated insulin secretion.

  1997cited by this paper
• Protein kinase A‐dependent and ‐independent stimulation of exocytosis by cAMP in mouse pancreatic B‐cells

  1997cited by this paper
• Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor.

  1996cited by this paper
• Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.

  1995cited by this paper
• Insulin-promoter-factor 1 is required for pancreas development in mice

  1994cited by this paper
• Glucose modulates the binding activity of the beta-cell transcription factor IUF1 in a phosphorylation-dependent manner.

  1994cited by this paper
• Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases.

  1987cited by this paper

• Disease-modifying pharmacological treatments of type 1 diabetes: Molecular mechanisms, target checkpoints, and possible combinatorial treatments

  2025cites this paper
• Glucose-dependent insulinotropic polypeptide (GIP)

  2025cites this paper
• Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus

  2025cites this paper
• Insulin as an Accelerator and Brake of Aging: From Molecular Landscape to Clinical Interventions

  2025cites this paper
• Human amniotic mesenchymal stem cell-islet organoids enhance the efficiency of islet engraftment in a mouse diabetes model.

  2024cites this paper
• Unlocking β-cell restoration: The crucial role of PDX1 in diabetes therapy.

  2024cites this paper
• Gymnema Sylvestre Supplementation Restores Normoglycemia, Corrects Dyslipidemia, and Transcriptionally Modulates Pancreatic and Hepatic Gene Expression in Alloxan-Induced Hyperglycemic Rats

  2023cites this paper
• A beneficial role of GLP-1 receptor agonist therapy in ABCC8-MODY (MODY 12).

  2023cites this paper
• Regulation of Pdx1 by oxidative stress and Nrf2 in pancreatic beta-cells

  2022cites this paper
• Single-nucleus RNA-Seq reveals singular gene signatures of human ductal cells during adaptation to insulin resistance

  2022cites this paper
• Biophysical insights into glucose-dependent transcriptional regulation by PDX1

  2022cites this paper
• Journal Pre-proof insights into glucose-dependent transcriptional regulation by PDX1

  2022cites this paper
• Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats

  2022cites this paper
• PDX-1: A Promising Therapeutic Target to Reverse Diabetes

  2022cites this paper
• Opportunities and challenges of polyphenols and polysaccharides for type 1 diabetes intervention

  2022cites this paper
• The transcription factor E2F1 controls the GLP-1 receptor pathway in pancreatic β cells.

  2022cites this paper
• A crosstalk between E2F1 and GLP-1 signaling pathways modulates insulin secretion

  2021cites this paper
• Metabolic responses and benefits of glucagon‐like peptide‐1 (GLP‐1) receptor ligands

  2021cites this paper
• The effects of exendin-4 on glucose homeostasis, pancreatic and duodenal homebox 1, and glucose transporter 2 gene expression disturbance induced by bisphenol A in male mice. The effects of exendin-4 on pancreatic gene expression

  2021cites this paper
• The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells

  2021cites this paper
• A missense KCNQ1 Mutation Impairs Insulin Secretion in Neonatal Diabetes

  2021cites this paper
• Phytochemicals modulate pancreatic islet β cell function through glucagon-like peptide-1-related mechanisms.

  2021cites this paper
• Maintaining Effective Beta Cell Function in the Face of Metabolic Syndrome-Associated Glucolipotoxicity—Nutraceutical Options

  2021cites this paper
• Physiological Role of Bile Acids Modified by the Gut Microbiome

  2021cites this paper
• Exendin-4 restores airway mucus homeostasis through the GLP1R-PKA-PPARγ-FOXA2-phosphatase signaling

  2020cites this paper
• Secreted PDZD2 exerts an insulinotropic effect on INS-1E cells by a PKA-dependent mechanism.

  2020cites this paper
• SCRT1 is a novel beta cell transcription factor with insulin regulatory properties.

  2020cites this paper
• Gut Peptide Agonism in the Treatment of Obesity and Diabetes.

  2019cites this paper
• Glucagon-like peptide 1 (GLP-1)

  2019cites this paper
• Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events

  2019cites this paper
• An incretin-based tri-agonist promotes superior insulin secretion from murine pancreatic islets via PLC activation.

  2018cites this paper
• The New Biology and Pharmacology of Glucagon.

  2017influential citation
• Dipeptidyl Peptidase-4 and Adolescent Idiopathic Scoliosis: Expression in Osteoblasts

  2017cites this paper
• Influence of Flavonoids on Mechanism of Modulation of Insulin Secretion

  2017cites this paper
• GLP-1 analogue recovers impaired insulin secretion from human islets treated with palmitate via down-regulation of SOCS2.

  2017cites this paper
• The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes.

  2017cites this paper
• Heterologous Expression and Delivery of Biologically Active Exendin-4 by Lactobacillus paracasei L14

  2016cites this paper
• Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

  2016cites this paper
• Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation.

  2016cites this paper
• Generation and function of glucose-responsive insulin producing cells derived from human induced pluripotent stem cells

  2015cites this paper
• cAMP-independent effects of GLP-1 on β cells.

  2015cites this paper
• The roles of pancreatic hormones in regulating pancreas development and beta cell regeneration

  2015cites this paper
• Beta Cell Function and the Nutritional State: Dietary Factors that Influence Insulin Secretion

  2015cites this paper
• Synthetic (+)‐antroquinonol exhibits dual actions against insulin resistance by triggering AMP kinase and inhibiting dipeptidyl peptidase IV activities

  2015influential citation
• Induction differentiation of rabbit adipose‑derived stromal cells into insulin‑producing cells in vitro.

  2015cites this paper
• EFFECT OF CINNAMOMUM CASSIA BARK EXTRACT ON GLUCOSE HOMEOSTASIS IN ALLOXAN-INDUCED DIABETIC RATS IN COMPARISON WITH DIRECT RENIN INHIBITOR (ALISKIREN) AND DIPEPTIDYL PEPTIDASE-IV INHIBITOR (SITAGLIPTIN)

  2015cites this paper
• GLP-1 analog liraglutide enhances proinsulin processing in pancreatic β-cells via a PKA-dependent pathway.

  2014cites this paper
• Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP‐1R activation

  2014cites this paper
• Apolipoprotein A-I Increases Insulin Secretion and Production From Pancreatic &bgr;-Cells via a G-Protein-cAMP-PKA-FoxO1–Dependent Mechanism

  2014cites this paper
• Regulation of glucose homeostasis by GLP-1.

  2014cites this paper
• Incretin-based therapies in prediabetes: Current evidence and future perspectives.

  2014cites this paper
• Pancreatic and duodenal homeobox-1 nuclear localization is regulated by glucose in dispersed rat islets but not in insulin-secreting cell lines

  2014cites this paper
• Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swine

  2013cites this paper
• Glucagon‐like peptide‐1: modulator of β‐cell dysfunction and death

  2013influential citation
• Update on the Protective Molecular Pathways Improving Pancreatic Beta-Cell Dysfunction

  2013cites this paper
• The DPP-4 inhibitor MK0626 and exercise protect islet function in early pre-diabetic kkay mice.

  2013cites this paper
• TWO Regulation of Glucose Homeostasis by GLP-1

  2013cites this paper
• PDX-1 Is a Therapeutic Target for Pancreatic Cancer, Insulinoma and Islet Neoplasia Using a Novel RNA Interference Platform

  2012cites this paper
• Deconstructing pancreas developmental biology.

  2012cites this paper
• Rôles du stress du réticulum endoplasmique et de l'immunité innée dans l'inhibition de la transcription du gène de l'insuline : étude du facteur de transcription ATF6 et du récepteur TLR4

  2012cites this paper
• Anti-Inflammatory Properties of Exenatide in Human Pancreatic Islets

  2012cites this paper
• Activation of the GLP-1 Receptor Signalling Pathway: A Relevant Strategy to Repair a Deficient Beta-Cell Mass

  2011cites this paper
• Lower expression of PKAα impairs insulin secretion in islets isolated from low-density lipoprotein receptor (LDLR(-/-)) knockout mice.

  2011cites this paper
• A novel therapeutic strategy for pancreatic neoplasia using a novel RNAi platform targeting PDX-1

  2011cites this paper
• Combination of TS-021 with metformin improves hyperglycemia and synergistically increases pancreatic β-cell mass in a mouse model of type 2 diabetes.

  2011cites this paper
• Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice.

  2010cites this paper
• Transferrin Fusion Technology: A Novel Approach to Prolonging Biological Half-Life of Insulinotropic Peptides

  2010cites this paper
• NADPH oxidase mediates glucolipotoxicity-induced beta cell dysfunction--clinical implications.

  2010cites this paper
• Treatment of diabetes with glucagon-like peptide-1 gene therapy

  2010cites this paper
• GLP-1 and Muscarinic Receptor Mediated Activation of ERK1/2 in Pancreatic β-cells

  2010cites this paper
• R-spondin-1 Is a Novel β-Cell Growth Factor and Insulin Secretagogue*

  2010cites this paper
• Lack of preservation of insulin gene expression by a glucagon-like peptide 1 agonist or a dipeptidyl peptidase 4 inhibitor in an in vivo model of glucolipotoxicity.

  2010cites this paper
• DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes

  2010cites this paper
• Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors.

  2009cites this paper
• Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.

  2009cites this paper
• Derivation of functional insulin-producing cell lines from primary mouse embryo culture.

  2009cites this paper
• Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.

  2008cites this paper
• Modulation of taste sensitivity by GLP‐1 signaling

  2008cites this paper
• Bipotential mouse embryonic liver (BMEL) cells spontaneously express Pdx1 and Ngn3 but do not undergo further pancreatic differentiation upon Hes1 down-regulation

  2008cites this paper
• Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus.

  2008cites this paper
• β-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic β cells

  2008cites this paper
• The Role of Incretins in Glucose Homeostasis and Diabetes Treatment

  2008cites this paper
• Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins.

  2008cites this paper
• Glucose regulation of insulin gene expression in pancreatic beta-cells.

  2008cites this paper
• Rapid And Efficient in Vitro Generation of Pancreatic Islet Progenitor Cells from Nonendocrine Epithelial Cells in The Adult Human Pancreas

  2007cites this paper
• Mechanism of genistein in the regulation of pancreatic beta-cell proliferation

  2007cites this paper
• Design, synthesis, and biological evaluation of substituted-N-(thieno[2,3-b]pyridin-3-yl)-guanidines, N-(1H-pyrrolo[2,3-b]pyridin-3-yl)-guanidines, and N-(1H-indol-3-yl)-guanidines.

  2007cites this paper
• Exenatide and biotin in conjunction with a protein-sparing fast for normalization of beta cell function in type 2 diabetics.

  2007cites this paper
• Mechanisms of action of glucagon-like peptide 1 in the pancreas.

  2007cites this paper
• Synthesis of 3,8,9-trisubstituted-1,7,9-triaza-fluorene-6-carboxylic acid derivatives as a new class of insulin secretagogues.

  2007cites this paper
• Synthesis and Antidiabetic Activity of 3,6,7‐Trisubstituted‐2‐(1H‐imidazol‐2‐ylsulfanyl)quinoxalines and Quinoxalin‐2‐yl isothioureas

  2007cites this paper
• Synthesis and antidiabetic activity of 2,5-disubstituted-3-imidazol-2-yl-pyrrolo[2,3-b]pyridines and thieno[2,3-b]pyridines.

  2007cites this paper
• Characterization of Pancreatic Transcription Factor Pdx-1 Binding Sites Using Promoter Microarray and Serial Analysis of Chromatin Occupancy*

  2007cites this paper
• Glucagon-like peptide 1: continued advances, new targets and expanding promise as a model therapeutic

  2007cites this paper
• Genistein acutely stimulates insulin secretion in pancreatic beta-cells through a cAMP-dependent protein kinase pathway.

  2006cites this paper
• Vildagliptin: a novel DPP-4 inhibitor with pancreatic islet enhancement activity for treatment of patients with type 2 diabetes.

  2006cites this paper
• GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress.

  2006cites this paper
• Inhibition of glucose-stimulated activation of extracellular signal-regulated protein kinases 1 and 2 by epinephrine in pancreatic beta-cells.

  2006cites this paper
• PDX-1 expression is associated with islet proliferation in vitro and in vivo.

  2006cites this paper
• Endoderm and Pancreatic Islet Lineage Differentiation from Human Embryonic Stem Cells

  2006cites this paper